Plasminogen activator inhibitor type 1 expression induced by lipopolysaccharide of Porphyromonas gingivalis in human gingival fibroblast

Journal of Microbiology

Volumn 52, Issue 2, 2014, Pages 154-160

  Na, Hee Sam ^a   Lim, Eun J ^a   Jeong, So Y ^a   Ryu, Mi H ^a   Park, Mi Hee ^a   Chung, Jin ^a  

^a Pusan National University   (South Korea)

Author keywords

PAI 1; periodontitis; Porphyromonas gingivalis

Indexed keywords

LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; BODY FLUID; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; GENETICS; GINGIVA; HUMAN; METABOLISM; PORPHYROMONAS GINGIVALIS;

BODY FLUIDS; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GINGIVA; HUMANS; LIPOPOLYSACCHARIDES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PORPHYROMONAS GINGIVALIS;

EID: 84893593584     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-014-3022-7     Document Type: Article

References (36)

1. Arndt, P. G., Young, S. K., and Worthen, G. S. 2005. Regulation of lipopolysaccharide-induced lung inflammation by plasminogen activator inhibitor-1 through a JNK-mediated pathway. J. Immunol. 175, 4049-4059.
2. Bainbridge, B. W. and Darveau, R. P. 2001. Porphyromonas gingivalis lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate host defense system. Acta. Odontol. Scand. 59, 131-138.
3. Cho, S. H., Ryu, C. H., and Oh, C. K. 2004. Plasminogen activator inhibitor-1 in the pathogenesis of asthma. Exp. Biol. Med. (Maywood)229, 138-146.
4. Curtis, M. A., Aduse-Opoku, J., and Rangarajan, M. 2001. Cysteine proteases of Porphyromonas gingivalis. Crit. Rev. Oral Biol. Med. 12, 192-216.
5. Czekay, R. P., Aertgeerts, K., Curriden, S. A., and Loskutoff, D. J. 2003. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J. Cell Biol. 160, 781-791.
6. Darveau, R. P. 2010. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 8, 481-490.
7. Deppe, H., Hohlweg-Majert, B., Holzle, F., Kesting, M. R., Wagenpfeil, S., Wolff, K. D., and Schmitt, M. 2010. Content of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in oral mucosa and inflamed periodontal tissue. Quintessence Int. 41, 165-171.
8. Dos Santos, S., Delattre, A. I., De Longueville, F., Bult, H., and Raes, M. 2007. Gene expression profiling of LPS-stimulated murine macrophages and role of the NF-kappaB and PI3K/mTOR signaling pathways. Ann. NY Acad. Sci. 1096, 70-77.
9. Eskan, M. A., Benakanakere, M. R., Rose, B. G., Zhang, P., Zhao, J., Stathopoulou, P., Fujioka, D., and Kinane, D. F. 2008. Interleukin-1beta modulates proinflammatory cytokine production in human epithelial cells. Infect. Immun. 76, 2080-2089.
10. Furuta, N., Takeuchi, H., and Amano, A. 2009. Entry of Porphyromonas gingivalis outer membrane vesicles into epithelial cells causes cellular functional impairment. Infect. Immun. 77, 4761-4770.
11. Gaibani, P., Caroli, F., Nucci, C., and Sambri, V. 2010. Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and matrix metalloproteinase 9 by primary human peripheral blood monocytes. J. Periodontal. Res. 45, 361-366.
12. Guan, S. M., He, J. J., Zhang, M., and Shu, L. 2011. Prevotella intermedia stimulates tissue-type plasminogen activator and plasminogen activator inhibitor-2 expression via multiple signaling pathways in human periodontal ligament cells. FEMS Immunol. Med. Microbiol. 62, 91-100.
13. Ha, Y. M., Chung, S. W., Kim, J. M., Kim, D. H., Kim, J. Y., Lee, E. K., Lee, J., Kim, Y. J., Yoo, M. A., Jeong, K. S., and Chung, H. Y. 2009. Molecular activation of NF-kappaB, pro-inflammatory mediators, and signal pathways in gamma-irradiated mice. Biotechnol. Lett. 32, 373-378.
14. Idell, S. 2003. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit. Care Med. 31, S213-220.
15. Imamura, T. 2003. The role of gingipains in the pathogenesis of periodontal disease. J. Periodontol. 74, 111-118.
16. Jonsson, D., Nebel, D., Bratthall, G., and Nilsson, B. O. 2010. The human periodontal ligament cell: a fibroblast-like cell acting as an immune cell. J. Periodontal Res. 46, 153-157.
17. Kinnby, B. 2002. The plasminogen activating system in periodontal health and disease. Biol. Chem. 383, 85-92.
18. Kinnby, B., Lindberg, P., Lecander, I., and Matsson, L. 1999. Localization of plasminogen activators and plasminogen-activator inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization. Arch. Oral Biol. 44, 1027-1034.
19. Kocgozlu, L., Elkaim, R., Tenenbaum, H., and Werner, S. 2009. Variable cell responses to P. gingivalis lipopolysaccharide. J. Dent. Res. 88, 741-745.
20. Kristoffersen, T., Maeland, J. A., and Hofstad, T. 1971. Serologic properties of lipopolysaccharide endotoxins from oral fusobacteria. Scand. J. Dent. Res. 79, 105-112.
21. Kruithof, E. K. 2008. Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb. Haemost. 100, 969-975.
22. Levi, M., Schultz, M. J., Rijneveld, A. W., and van der Poll, T. 2003. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit. Care Med. 31, S238-242.
23. McMahon, G. A., Petitclerc, E., Stefansson, S., Smith, E., Wong, M. K., Westrick, R. J., Ginsburg, D., Brooks, P. C., and Lawrence, D. A. 2001. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem. 276, 33964-33968.
24. Na, H. S., Kim, J. S., and Chung, J. 2012. Identification of differentially expressed genes using an annealing control primer system in periodontitis. Int. J. Oral Biol. 37, 6.
25. Ogawa, T., Asai, Y., Makimura, Y., and Tamai, R. 2007. Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A. Front Biosci. 12, 3795-3812.
26. Saetre, T., Lindgaard, A. K., and Lyberg, T. 2000. Systemic activation of coagulation and fibrynolysis in a porcine model of serogroup A streptococcal shock. Blood Coagul. Fibrinolysis11, 433-438.
27. Sakata, Y., Murakami, T., Noro, A., Mori, K., and Matsuda, M. 1991. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia. Blood77, 1949-1957.
28. Senzaki, H., Kobayashi, T., Nagasaka, H., Nakano, H., Kyo, S., Yokote, Y., and Sasakid, N. 2003. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy. Pediatr. Res. 53, 983-988.
29. Slaney, J. M. and Curtis, M. A. 2008. Mechanisms of evasion of complement by Porphyromonas gingivalis. Front Biosci. 13, 188-196.
30. Tas, S. W., Remans, P. H., Reedquist, K. A., and Tak, P. P. 2005. Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapy. Curr. Pharm. Des. 11, 581-611.
31. Wang, D., Paz-Priel, I., and Friedman, A. D. 2009. NF-kappa B p50 regulates C/EBP alpha expression and inflammatory cytokinenduced neutrophil production. J. Immunol. 182, 5757-5762.
32. Wullaert, A., Bonnet, M. C., and Pasparakis, M. 2010. NF-kappaB in the regulation of epithelial homeostasis and inflammation. Cell Res. 21, 146-158.
33. Xiao, Y., Bunn, C. L., and Bartold, P. M. 1998. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts. J. Periodontal Res. 33, 17-26.
34. Xu, Y., Hagege, J., Mougenot, B., Sraer, J. D., Ronne, E., and Rondeau, E. 1996. Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int. 50, 2011-2019.
35. Xu, X., Wang, H., Wang, Z., and Xiao, W. 2009. Plasminogen activator inhibitor-1 promotes inflammatory process induced by cigarette smoke extraction or lipopolysaccharides in alveolar epithelial cells. Exp. Lung Res. 35, 795-805.
36. Yu, W. H., Hu, H., Zhou, Q., Xia, Y., and Amar, S. 2011. Bioinformatics analysis of macrophages exposed to Porphyromonas gingivalis: implications in acute vs. chronic infections. PLoS One5, e15613.